We systematically evaluated the impact of the presence or absence of APOE on neuronal function and synaptic integrity in mice that develop plaques (APP/PSEN1 mice expressing both the human mutated Amyloid precursor protein, APP, and presenilin-1, PSEN1, genes) and those without increased amyloidosis (wild-type). This evidence concerns the gene APP and amyloidosis.